Cargando…
Colorectal Cancer Biomarkers and the Potential Role of Cancer Stem Cells
Over 50% of patients with colorectal cancer (CRC) will progress and/or develop metastases. Biomarkers capable of predicting progression, risk stratification and therapeutic benefit are needed. Cancer stem cells are thought to be responsible for tumor initiation, dissemination and treatment failure....
Autores principales: | Langan, Russell C., Mullinax, John E., Raiji, Manish T., Upham, Trevor, Summers, Thomas, Stojadinovic, Alexander, Avital, Itzhak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584837/ https://www.ncbi.nlm.nih.gov/pubmed/23459666 http://dx.doi.org/10.7150/jca.5832 |
Ejemplares similares
-
A Pilot Study Assessing the Potential Role of non-CD133 Colorectal Cancer Stem Cells as Biomarkers
por: Langan, Russell C., et al.
Publicado: (2012) -
Serum-Based DNA Methylation Biomarkers in Colorectal Cancer: Potential for Screening and Early Detection
por: Summers, Thomas, et al.
Publicado: (2013) -
Establishment of Human Ultra-Low Passage Colorectal Cancer Cell Lines Using Spheroids from Fresh Surgical Specimens Suitable for In Vitro and In Vivo Studies
por: Ray, Satyajit, et al.
Publicado: (2012) -
Special Issue on Precision Risk Stratification-Based Screening in Colorectal Cancer
por: Stojadinovic, Alexander, et al.
Publicado: (2013) -
Patients at Risk for Peritoneal Surface Malignancy of Colorectal Cancer Origin: The Role of Second Look Laparotomy
por: Brücher, Björn LDM, et al.
Publicado: (2013)